Training postdoctoral researchers in translational science at Scripps Research
Official title: CTSA Postdoctoral T32 at The Scripps Research Institute
Funded at Scripps Research Institute, the · NIH-10764680 · Data updated 2026-11-12
This program at Scripps Research is designed to help new scientists learn how to turn lab discoveries into real treatments for patients, especially encouraging those from diverse backgrounds to join in and make a difference in understanding and treating diseases.
Quick facts
| Grant type | Training grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Scripps Research Institute, the NIH-funded |
| Lab location | 1 site (La Jolla, United States) |
| Project start | August 5, 2024 |
| Project end | July 31, 2029 |
| Funding year | 2024 |
| Award (this year) | $256,717 |
| NIH project number | 1T32TR004396-01A1 |
| Project ID | NIH-10764680 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are early-career scientists and postdoctoral fellows interested in translational research and its applications in clinical settings.
✕Less likely to help
Patients who are not involved in scientific training or do not have a background in research may not directly benefit from this program.
What this research studies
This program at Scripps Research focuses on training postdoctoral fellows in the field of translational research, which bridges basic science and clinical applications. Participants will engage in a comprehensive educational experience that includes interdisciplinary training in genomics, data analysis, and biological measurements. The program emphasizes the importance of diversity and inclusion, encouraging scientists from underrepresented backgrounds to participate and contribute to outreach initiatives. By integrating patient data and specimens into research, the program aims to enhance the understanding of diseases and improve future treatment options.
Why it matters
Potential benefit: If successful, this research could lead to improved drug development processes and better patient outcomes through enhanced translational science.
How similar studies have gone: Similar programs in translational research have shown success in enhancing drug development and improving clinical outcomes, making this approach promising.
Where this research is happening
-
Scripps Research Institute, the
La Jolla, United States Active
Researchers
- Principal investigator: Lamia, Katja a — Scripps Research Institute, the
- Study coordinator: Lamia, Katja a
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.